In pediatric NB and MB, transcription factor MYCN binds Aurora kinase A, thus attenuating G2/M arrest and stabilizing MYCN protein (136), and conversely inhibition of Aurora kinase A promotes MYCN degradation and cell death (71, 137, 138). The gene discussed is MYCN; the disease is neuroblastoma.